Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/25/2010 | CA2762095A1 Compositions comprising cationic amphiphiles and colipids for delivering therapeutics molecules |
11/24/2010 | EP2253718A2 Solid surface for biomolecule delivery and high-throughput assay |
11/24/2010 | EP2253330A2 Conjugated biological molecules and their preparation |
11/24/2010 | EP2253329A1 Ibuprofen lysinate oral suspension |
11/24/2010 | EP2253326A1 Pharmaceutical composition for transnasal administration |
11/24/2010 | EP2253325A1 Agent for enhancing corneal epithelial barrier function |
11/24/2010 | EP2253322A1 Method and composition containing latanoprost for treating ocular hypertension and glaucoma |
11/24/2010 | EP2253318A1 Improvement of dissolvability of preparation containing olmesartan medoxomil |
11/24/2010 | EP2253314A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
11/24/2010 | EP2253224A1 Ondansetron film compositions |
11/24/2010 | EP2252635A2 Carrageenan modified by ion-exchange process |
11/24/2010 | EP2252328A2 Intracellular enzyme and receptor modulation |
11/24/2010 | EP2252315A1 Improved antitumoral treatments |
11/24/2010 | EP2252305A2 Omentum and use thereof |
11/24/2010 | EP2252291A1 Pharmaceutical composition |
11/24/2010 | EP2252284A1 Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability |
11/24/2010 | EP2252269A1 Casein particles encapsulating therapeutically active agents and uses thereof |
11/24/2010 | EP2252267A2 Lyophilized nanoemulsion |
11/24/2010 | EP2252266A1 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
11/24/2010 | EP2252262A1 Method to enhance aqueous solubility of poorly soluble actives using methoxypolyethylene glycol |
11/24/2010 | EP2252261A2 Drug delivery system with stabilising effect |
11/24/2010 | EP2252254A2 Compositions and devices |
11/24/2010 | EP2063868B1 Pharmaceutical compositions containing rosuvastatin calcium |
11/24/2010 | EP1940353B1 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
11/24/2010 | EP1937310B1 Use of conjugates of doxorubicin with lactosaminated albumin |
11/24/2010 | EP1932525B1 Skin-care preparations containing mupirocin and betamethasone dipropionate |
11/24/2010 | EP1799191B1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
11/24/2010 | EP1714653B1 Aqueous solution preparation containing a camptothecin |
11/24/2010 | EP1562585B1 Daily melatonin dosing units |
11/24/2010 | EP1545621B1 Pharmaceutical compositions comprising complexes of phosphate derivatives of lipophilic compounds |
11/24/2010 | EP1539739B1 Piperidinyl compounds that selectively bind integrins |
11/24/2010 | EP1434840B1 Low-viscosity opacifiers free from anionic surface-active agents |
11/24/2010 | EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
11/24/2010 | EP1276486B1 Joint repair using mesenchymal stem cells |
11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
11/24/2010 | CN1960705B Therapeutic foam |
11/24/2010 | CN1947796B Chemical modified adefovir and tynofovir |
11/24/2010 | CN1942181B Tablet containing branched chain amino acid and process for producing the same |
11/24/2010 | CN1929868B Lyposome-containing x ray-imaging agent and method for producing the same |
11/24/2010 | CN1816564B Rasgap derived peptide for selectively killing cancer cells |
11/24/2010 | CN101896595A Bactericidal cleanser composition |
11/24/2010 | CN101896500A Immune modulation via C-type lectin |
11/24/2010 | CN101896207A Quarternization of the additive amino alkyl methacrylate copolymer e for improving permeability and solubility of pharmaceuticals |
11/24/2010 | CN101896206A Carboxymethylcellulose polyethylene glycol compositions for medical uses |
11/24/2010 | CN101896199A Pharmaceutical formulation comprising hepatitis B virus neutralizing human antibody |
11/24/2010 | CN101896191A System for delivery into a XCR1 positive cell and uses thereof |
11/24/2010 | CN101896179A Tape preparation comprising etodolac in ionic liquid form |
11/24/2010 | CN101896175A Loxoprofen-containing aqueous plaster |
11/24/2010 | CN101896168A Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release |
11/24/2010 | CN101896164A Process for producing biological ingesta and biological ingesta obtained thereby |
11/24/2010 | CN101896163A Antibody formulation |
11/24/2010 | CN101896155A Skin external preparation and method of producing the same |
11/24/2010 | CN101891962A Preparation method of silk fibroin porous three-dimensional material |
11/24/2010 | CN101891890A Method for preparing biodegradable poly (alpha, beta-L-aspartic acid) |
11/24/2010 | CN101891870A Amphiphilic copolymer brush with pH responsiveness, preparation method thereof and use thereof |
11/24/2010 | CN101891826A Targeted hIL-10 recombinant protein and application thereof |
11/24/2010 | CN101891825A Recombinant fusion proteins of hepatitis B core proteins and tuberculosis antigen or antigen fragments and application thereof |
11/24/2010 | CN101891823A Exendin-4 and analog fusion protein thereof |
11/24/2010 | CN101891822A Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability |
11/24/2010 | CN101891821A T1R hetero-oligomeric taste receptor, and cell line expressing the receptor, and use thereof for identification of tasty compound |
11/24/2010 | CN101891814A Anti-osteopontin OPN monoclonal antibody and application thereof |
11/24/2010 | CN101891803A New cartilaginous affinity polypeptide sequence, screening method and application thereof |
11/24/2010 | CN101891801A Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof |
11/24/2010 | CN101891800A Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof |
11/24/2010 | CN101891783A Flavone-metal complex microsphere and preparation method and application thereof |
11/24/2010 | CN101891732A Cyclic carbonate monomer and preparing method thereof |
11/24/2010 | CN101890171A Inclusion complex of raloxifene hydrochloride and beta-cyclodextrin |
11/24/2010 | CN101890170A Nanostructured lipid carrier, preparation method and application thereof |
11/24/2010 | CN101890169A Moxifloxacin oral preparation and preparation method thereof |
11/24/2010 | CN101890168A Biodegradable block copolymeric compositions for drug delivery |
11/24/2010 | CN101890167A Conveniently implantable sustained release drug compositions |
11/24/2010 | CN101890121A External medicinal composition for treating acute soft tissue injury and preparation method and application thereof |
11/24/2010 | CN101890109A Medicament for treating cardiovascular and cerebrovascular diseases |
11/24/2010 | CN101890108A Prescription and preparation method of mixture for relieving pain and arresting diarrhea |
11/24/2010 | CN101890078A Traditional Chinese medicinal tablets for treating lumbar spinal stenosis and production method thereof |
11/24/2010 | CN101890065A Inula flower injection and preparation method thereof |
11/24/2010 | CN101890045A External medicament for treating infantile eczema |
11/24/2010 | CN101890028A Stabilized pharmaceutical composition |
11/24/2010 | CN101890026A Water soluble vitamin D2 and calcium colloid injection medicinal composition |
11/24/2010 | CN101890024A Candesartan cilexetil/hydrochlorothiazide composition and preparation method thereof |
11/24/2010 | CN101890023A Cefuroxime axetil oral liquid and preparation method thereof |
11/24/2010 | CN101890013A Pitavastatin calcium composition stabilized by using alkaline reagent and preparation method thereof |
11/24/2010 | CN101890006A Amoxicillin sustained-release preparation composition and preparation method thereof |
11/24/2010 | CN101890005A Amoxicillin/clavulanate potassium enteric-coated preparation composition and preparation method thereof |
11/24/2010 | CN101890004A Amoxicillin/potassium clavulanate sustained-release preparation composition and preparation method thereof |
11/24/2010 | CN101889997A Ibuprofen-containing medicinal composition for injection |
11/24/2010 | CN101889996A Rectal administration composition containing tamsulosin |
11/24/2010 | CN101889994A Salbutamol sulfate sustained-release aerosol of micropowder for inspiration and preparation method thereof |
11/24/2010 | CN101889993A Surface-modified salbutamol suspension type non-Freon inhalation aerosol and preparation method thereof |
11/24/2010 | CN101889990A Ondansetron film compositions |
11/24/2010 | CN101889989A Amoxicillin enteric controlled-release preparation composite and preparation method thereof |
11/24/2010 | CN101889988A Tiamulin fumarate effervescent granules for treating pneumonia and dysentery of livestock and poultry |
11/24/2010 | CN101889985A Medicament-carrying nano microspheres and preparation method thereof |
11/24/2010 | CN101889984A Amoxicillin enteric-coated formulation composition and preparation method thereof |
11/24/2010 | CN101889983A PEG-PLGA nanoparticle carrying recombinant human vascular endothelial inhibitor and preparation method thereof |
11/24/2010 | CN101889982A Novel long-circulating liposome composition and preparation method thereof |
11/24/2010 | CN101889981A Stable liposome compositions comprising lipophilic amine containing pharmaceutical agents |
11/24/2010 | CN101889980A Compound thermo-sensitive liposome used for thermal targeted chemotherapy and preparation method thereof |
11/24/2010 | CN101889979A Itraconazole injection for dogs and preparation method thereof |